UPDATE: JP Morgan Upgrades Eli Lilly to Neutral

JP Morgan raises its rating on Eli Lilly LLY to Neutral from Underweight as downside is limited through cost cuts. Price target is at $40 a share on Thursday. JP Morgan says, "Since our downgrade of LLY shares in September 2008, we have viewed the stock as having an unattractive risk/reward as a result of limited pipeline clarity, expense growth depressing margins and a looming patent cliff. However, as we now look out over the next 12-18 months, in our view, we are approaching a period during which either Lilly's pipeline will succeed or the company will need to more significantly reevaluate its overall cost structure." LLY closed at $39.35 a share on Thursday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorUpgradesPrice TargetIntraday UpdateAnalyst RatingsJP Morgan
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!